Your browser doesn't support javascript.
loading
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.
Solimando, A G; Brandl, A; Mattenheimer, K; Graf, C; Ritz, M; Ruckdeschel, A; Stühmer, T; Mokhtari, Z; Rudelius, M; Dotterweich, J; Bittrich, M; Desantis, V; Ebert, R; Trerotoli, P; Frassanito, M A; Rosenwald, A; Vacca, A; Einsele, H; Jakob, F; Beilhack, A.
Afiliación
  • Solimando AG; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research Laboratory, University Hospital of Würzburg, Würzburg, Germany.
  • Brandl A; Division of Hematology and Oncology, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Mattenheimer K; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine 'G. Baccelli', University of Bari Medical School Bari, Bari, Italy.
  • Graf C; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research Laboratory, University Hospital of Würzburg, Würzburg, Germany.
  • Ritz M; Division of Hematology and Oncology, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Ruckdeschel A; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research Laboratory, University Hospital of Würzburg, Würzburg, Germany.
  • Stühmer T; Division of Hematology and Oncology, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Mokhtari Z; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research Laboratory, University Hospital of Würzburg, Würzburg, Germany.
  • Rudelius M; Division of Hematology and Oncology, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Dotterweich J; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research Laboratory, University Hospital of Würzburg, Würzburg, Germany.
  • Bittrich M; Division of Hematology and Oncology, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Desantis V; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research Laboratory, University Hospital of Würzburg, Würzburg, Germany.
  • Ebert R; Division of Hematology and Oncology, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Trerotoli P; Department of Internal Medicine II, Chair of Translational Oncology, University Hospital of Würzburg, Würzburg, Germany.
  • Frassanito MA; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research Laboratory, University Hospital of Würzburg, Würzburg, Germany.
  • Rosenwald A; Division of Hematology and Oncology, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Vacca A; Institute of Pathology, University of Würzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
  • Einsele H; Orthopedic Department, Orthopedic Center for Musculoskeletal Research, University of Würzburg, Würzburg, Germany.
  • Jakob F; Division of Hematology and Oncology, Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Beilhack A; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine 'G. Baccelli', University of Bari Medical School Bari, Bari, Italy.
Leukemia ; 32(3): 736-743, 2018 03.
Article en En | MEDLINE | ID: mdl-29064484

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Molécula A de Adhesión de Unión / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Molécula A de Adhesión de Unión / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article